-
1
-
-
0032541845
-
Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)
-
DOI 10.1016/S0140-6736(98)08020-9
-
Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, Larrue V, Bluhmki E, Davis S, Donnan G, Schneider D, Diez-Tejedor E, Trouillas P: Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998; 352: 1245-1251. (Pubitemid 28470336)
-
(1998)
Lancet
, vol.352
, Issue.9136
, pp. 1245-1251
-
-
Hacke, W.1
Kaste, M.2
Fieschi, C.3
Von Kummer, R.4
Davalos, A.5
Meier, D.6
Larrue, V.7
Bluhmki, E.8
Davis, S.9
Donnan, G.10
Schneider, D.11
Diez-Tejedor, E.12
Trouillas, P.13
-
2
-
-
0029050323
-
Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke
-
The European Cooperative Acute Stroke Study (ECASS)
-
Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Hoxter G, Mahagne MH, et al: Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995; 274: 1017-1025.
-
(1995)
JAMA
, vol.274
, pp. 1017-1025
-
-
Hacke, W.1
Kaste, M.2
Fieschi, C.3
Toni, D.4
Lesaffre, E.5
Von Kummer, R.6
Boysen, G.7
Bluhmki, E.8
Hoxter, G.9
Mahagne, M.H.10
-
3
-
-
77954176107
-
Off-label thrombolysis is not associated with poor outcome in patients with stroke
-
Meretoja A, Putaala J, Tatlisumak T, Atula S, Artto V, Curtze S, Happola O, Lindsberg PJ, Mustanoja S, Piironen K, Pitkaniemi J, Rantanen K, Sairanen T, Salonen O, Silvennoinen H, Soinne L, Strbian D, Tiainen M, Kaste M: Off-label thrombolysis is not associated with poor outcome in patients with stroke. Stroke 2010; 41: 1450-1458.
-
(2010)
Stroke
, vol.41
, pp. 1450-1458
-
-
Meretoja, A.1
Putaala, J.2
Tatlisumak, T.3
Atula, S.4
Artto, V.5
Curtze, S.6
Happola, O.7
Lindsberg, P.J.8
Mustanoja, S.9
Piironen, K.10
Pitkaniemi, J.11
Rantanen, K.12
Sairanen, T.13
Salonen, O.14
Silvennoinen, H.15
Soinne, L.16
Strbian, D.17
Tiainen, M.18
Kaste, M.19
-
4
-
-
67650045788
-
Is it time to reassess the SITS-MOST criteria for thrombolysis? a comparison of patients with and without SITS-MOST exclusion criteria
-
Rubiera M, Ribo M, Santamarina E, Maisterra O, Delgado-Mederos R, Delgado P, Ortega G, Alvarez-Sabin J, Molina CA: Is it time to reassess the SITS-MOST criteria for thrombolysis?: A comparison of patients with and without SITS-MOST exclusion criteria. Stroke 2009; 40: 2568-2571.
-
(2009)
Stroke
, vol.40
, pp. 2568-2571
-
-
Rubiera, M.1
Ribo, M.2
Santamarina, E.3
Maisterra, O.4
Delgado-Mederos, R.5
Delgado, P.6
Ortega, G.7
Alvarez-Sabin, J.8
Molina, C.A.9
-
5
-
-
52649165720
-
Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke
-
Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D: Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008; 359: 1317-1329.
-
(2008)
N Engl J Med
, vol.359
, pp. 1317-1329
-
-
Hacke, W.1
Kaste, M.2
Bluhmki, E.3
Brozman, M.4
Davalos, A.5
Guidetti, D.6
Larrue, V.7
Lees, K.R.8
Medeghri, Z.9
Machnig, T.10
Schneider, D.11
Von Kummer, R.12
Wahlgren, N.13
Toni, D.14
-
6
-
-
33745949968
-
MRI versus CT-based thrombolysis treatment within and beyond the 3 h time window after stroke onset: A cohort study
-
DOI 10.1016/S1474-4422(06)70499-9, PII S1474442206704999
-
Kohrmann M, Juttler E, Fiebach JB, Huttner HB, Siebert S, Schwark C, Ringleb PA, Schellinger PD, Hacke W: MRI versus CTbased thrombolysis treatment within and beyond the 3 h time window after stroke onset: A cohort study. Lancet Neurol 2006; 5: 661-667. (Pubitemid 44062409)
-
(2006)
Lancet Neurology
, vol.5
, Issue.8
, pp. 661-667
-
-
Kohrmann, M.1
Juttler, E.2
Fiebach, J.B.3
Huttner, H.B.4
Siebert, S.5
Schwark, C.6
Ringleb, P.A.7
Schellinger, P.D.8
Hacke, W.9
-
7
-
-
44449094159
-
Guidelines for management of ischaemic stroke and transient ischaemic attack
-
European Stroke Organisation (ESO) Executive Committee, ESO Writing Committee 2008
-
European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee: Guidelines for management of ischaemic stroke and transient ischaemic attack 2008.
-
Cerebrovasc Dis 2008
, vol.25
, pp. 457-507
-
-
-
8
-
-
33846592841
-
Hemorrhagic complications after off-label thrombolysis for ischemic stroke
-
DOI 10.1161/01.STR.0000254504.71955.05, PII 0000767020070200000054
-
Aleu A, Mellado P, Lichy C, Kohrmann M, Schellinger PD: Hemorrhagic complications after off-label thrombolysis for ischemic stroke. Stroke 2007; 38: 417-422. (Pubitemid 46184319)
-
(2007)
Stroke
, vol.38
, Issue.2
, pp. 417-422
-
-
Aleu, A.1
Mellado, P.2
Lichy, C.3
Kohrmann, M.4
Schellinger, P.D.5
-
9
-
-
33846347159
-
Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): An observational study
-
DOI 10.1016/S0140-6736(07)60149-4, PII S0140673607601494
-
Wahlgren N, Ahmed N, Davalos A, Ford GA, Grond M, Hacke W, Hennerici MG, Kaste M, Kuelkens S, Larrue V, Lees KR, Roine RO, Soinne L, Toni D, Vanhooren G: Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): An observational study. Lancet 2007; 369: 275-282. (Pubitemid 46138121)
-
(2007)
Lancet
, vol.369
, Issue.9558
, pp. 275-282
-
-
Wahlgren, N.1
Ahmed, N.2
Davalos, A.3
Ford, G.A.4
Grond, M.5
Hacke, W.6
Hennerici, M.G.7
Kaste, M.8
Kuelkens, S.9
Larrue, V.10
Lees, K.R.11
Roine, R.O.12
Soinne, L.13
Toni, D.14
Vanhooren, G.15
-
10
-
-
34247844511
-
Guidelines for the early management of adults with ischemic stroke: A guideline from the American Heart Association
-
American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists
-
Adams HP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, Grubb RL, Higashida RT, Jauch EC, Kidwell C, Lyden PD, Morgenstern LB, Qureshi AI, Rosenwasser RH, Scott PA, Wijdicks EF: Guidelines for the early management of adults with ischemic stroke: A guideline from the American Heart Association/ American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007; 38: 1655-1711.
-
(2007)
Stroke
, vol.38
, pp. 1655-1711
-
-
Adams Jr., H.P.1
Del Zoppo, G.2
Alberts, M.J.3
Bhatt, D.L.4
Brass, L.5
Furlan, A.6
Grubb, R.L.7
Higashida, R.T.8
Jauch, E.C.9
Kidwell, C.10
Lyden, P.D.11
Morgenstern, L.B.12
Qureshi, A.I.13
Rosenwasser, R.H.14
Scott, P.A.15
Wijdicks, E.F.16
-
11
-
-
0028783948
-
The national institute of neurological disorders and stroke rt-PA stroke study group
-
Tissue plasminogen activator for acute ischemic stroke
-
Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995; 333: 1581-1587.
-
(1995)
N Engl J Med
, vol.333
, pp. 1581-1587
-
-
-
12
-
-
0033485522
-
Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: A randomized controlled trial
-
Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke
-
Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S: Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: A randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA 1999; 282: 2019-2026.
-
(1999)
JAMA
, vol.282
, pp. 2019-2026
-
-
Clark, W.M.1
Wissman, S.2
Albers, G.W.3
Jhamandas, J.H.4
Madden, K.P.5
Hamilton, S.6
-
13
-
-
13844321929
-
Reasons for exclusion from thrombolytic therapy following acute ischemic stroke
-
Cocho D, Belvis R, Marti-Fabregas J, Molina-Porcel L, Diaz-Manera J, Aleu A, Pagonabarraga J, Garcia-Bargo D, Mauri A, Marti-Vilalta JL: Reasons for exclusion from thrombolytic therapy following acute ischemic stroke. Neurology 2005; 64: 719-720. (Pubitemid 40261906)
-
(2005)
Neurology
, vol.64
, Issue.4
, pp. 719-720
-
-
Cocho, D.1
Belvis, R.2
Marti-Fabregas, J.3
Molina-Porcel, L.4
Diaz-Manera, J.5
Aleu, A.6
Pagonabarraga, J.7
Garcia-Bargo, D.8
Mauri, A.9
Marti-Vilalta, J.-L.10
-
14
-
-
1542298170
-
Utilization of intravenous tissue plasminogen activator for acute ischemic stroke
-
DOI 10.1001/archneur.61.3.346
-
Katzan IL, Hammer MD, Hixson ED, Furlan AJ, Abou-Chebl A, Nadzam DM: Utilization of intravenous tissue plasminogen activator for acute ischemic stroke. Arch Neurol 2004; 61: 346-350. (Pubitemid 38327350)
-
(2004)
Archives of Neurology
, vol.61
, Issue.3
, pp. 346-350
-
-
Katzan, I.L.1
Hammer, M.D.2
Hixson, E.D.3
Furlan, A.J.4
Abou-Chebl, A.5
Nadzam, D.M.6
-
15
-
-
78149360435
-
Strokes with minor symptoms An exploratory analysis of the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator trials
-
Khatri P, Kleindorfer DO, Yeatts SD, Saver JL, Levine SR, Lyden PD, Moomaw CJ, Palesch YY, Jauch EC, Broderick JP: Strokes with minor symptoms. An exploratory analysis of the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator trials. Stroke 2010; 41: 2581-2586.
-
(2010)
Stroke
, vol.41
, pp. 2581-2586
-
-
Khatri, P.1
Kleindorfer, D.O.2
Yeatts, S.D.3
Saver, J.L.4
Levine, S.R.5
Lyden, P.D.6
Moomaw, C.J.7
Palesch, Y.Y.8
Jauch, E.C.9
Broderick, J.P.10
-
16
-
-
1642602666
-
Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: A population-based study
-
Kleindorfer D, Kissela B, Schneider A, Woo D, Khoury J, Miller R, Alwell K, Gebel J, Szaflarski J, Pancioli A, Jauch E, Moomaw C, Shukla R, Broderick JP: Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: A population-based study. Stroke 2004; 35:e27-e29.
-
(2004)
Stroke
, vol.35
-
-
Kleindorfer, D.1
Kissela, B.2
Schneider, A.3
Woo, D.4
Khoury, J.5
Miller, R.6
Alwell, K.7
Gebel, J.8
Szaflarski, J.9
Pancioli, A.10
Jauch, E.11
Moomaw, C.12
Shukla, R.13
Broderick, J.P.14
-
17
-
-
34548220032
-
Outcome of stroke with mild or rapidly improving symptoms
-
DOI 10.1161/STROKEAHA.107.482554, PII 0000767020070900000024
-
Nedeltchev K, Schwegler B, Haefeli T, Brekenfeld C, Gralla J, Fischer U, Arnold M, Remonda L, Schroth G, Mattle HP: Outcome of stroke with mild or rapidly improving symptoms. Stroke 2007; 38: 2531-2535. (Pubitemid 47329633)
-
(2007)
Stroke
, vol.38
, Issue.9
, pp. 2531-2535
-
-
Nedeltchev, K.1
Schwegler, B.2
Haefeli, T.3
Brekenfeld, C.4
Gralla, J.5
Fischer, U.6
Arnold, M.7
Remonda, L.8
Schroth, G.9
Mattle, H.P.10
-
18
-
-
33749037692
-
Early MRI and outcomes of untreated patients with mild or improving ischemic stroke
-
DOI 10.1212/01.wnl.0000237520.88777.71, PII 0000611420060926000015
-
Rajajee V, Kidwell C, Starkman S, Ovbiagele B, Alger JR, Villablanca P, Vinuela F, Duckwiler G, Jahan R, Fredieu A, Suzuki S, Saver JL: Early MRI and outcomes of untreated patients with mild or improving ischemic stroke. Neurology 2006; 67: 980-984. (Pubitemid 44454588)
-
(2006)
Neurology
, vol.67
, Issue.6
, pp. 980-984
-
-
Rajajee, V.1
Kidwell, C.2
Starkman, S.3
Ovbiagele, B.4
Alger, J.R.5
Villablanca, P.6
Vinuela, F.7
Duckwiler, G.8
Jahan, R.9
Fredieu, A.10
Suzuki, S.11
Saver, J.L.12
-
19
-
-
27644516008
-
Outcome and severe hemorrhagic complications of intravenous thrombolysis with tissue plasminogen activator in very old (≥80 years) stroke patients
-
DOI 10.1161/01.STR.0000185696.73938.e0
-
Berrouschot J, Rother J, Glahn J, Kucinski T, Fiehler J, Thomalla G: Outcome and severe hemorrhagic complications of intravenous thrombolysis with tissue plasminogen activator in very old ( 1 or = 80 years) stroke patients. Stroke 2005; 36: 2421-2425. (Pubitemid 41566970)
-
(2005)
Stroke
, vol.36
, Issue.11
, pp. 2421-2425
-
-
Berrouschot, J.1
Rother, J.2
Glahn, J.3
Kucinski, T.4
Fiehler, J.5
Thomalla, G.6
-
20
-
-
33750326886
-
Intravenous thrombolysis in stroke patients of ≥80 versus <80 years of age - A systematic review across cohort studies
-
DOI 10.1093/ageing/afl104
-
Engelter ST, Bonati LH, Lyrer PA: Intravenous thrombolysis in stroke patients of 1 or = 80 versus ! 80 years of age -a systematic review across cohort studies. Age Ageing 2006; 35: 572-580. (Pubitemid 44614151)
-
(2006)
Age and Ageing
, vol.35
, Issue.6
, pp. 572-580
-
-
Engelter, S.T.1
Bonati, L.H.2
Lyrer, P.A.3
-
21
-
-
33645077927
-
Thrombolysis in stroke patients aged 80 years and older: Swiss survey of IV thrombolysis
-
Engelter ST, Reichhart M, Sekoranja L, Georgiadis D, Baumann A, Weder B, Muller F, Luthy R, Arnold M, Michel P, Mattle HP, Tettenborn B, Hungerbuhler HJ, Baumgartner RW, Sztajzel R, Bogousslavsky J, Lyrer PA: Thrombolysis in stroke patients aged 80 years and older: Swiss survey of IV thrombolysis. Neurology 2005; 65: 1795-1798.
-
(2005)
Neurology
, vol.65
, pp. 1795-1798
-
-
Engelter, S.T.1
Reichhart, M.2
Sekoranja, L.3
Georgiadis, D.4
Baumann, A.5
Weder, B.6
Muller, F.7
Luthy, R.8
Arnold, M.9
Michel, P.10
Mattle, H.P.11
Tettenborn, B.12
Hungerbuhler, H.J.13
Baumgartner, R.W.14
Sztajzel, R.15
Bogousslavsky, J.16
Lyrer, P.A.17
-
22
-
-
33745309395
-
Thrombolysis in patients older than 80 years with acute ischaemic stroke: Canadian Alteplase for Stroke Effectiveness Study
-
DOI 10.1136/jnnp.2005.086595
-
Sylaja PN, Cote R, Buchan AM, Hill MD: Thrombolysis in patients older than 80 years with acute ischaemic stroke: Canadian Alteplase for Stroke Effectiveness Study. J Neurol Neurosurg Psychiatry 2006; 77: 826-829. (Pubitemid 44023176)
-
(2006)
Journal of Neurology, Neurosurgery and Psychiatry
, vol.77
, Issue.7
, pp. 826-829
-
-
Sylaja, P.N.1
Cote, R.2
Buchan, A.M.3
Hill, M.D.4
-
23
-
-
0033951942
-
Intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 80 years and older: The tPA stroke survey experience
-
Tanne D, Gorman MJ, Bates VE, Kasner SE, Scott P, Verro P, Binder JR, Dayno JM, Schultz LR, Levine SR: Intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 80 years and older: The tPA stroke survey experience. Stroke 2000; 31: 370-375. (Pubitemid 30078168)
-
(2000)
Stroke
, vol.31
, Issue.2
, pp. 370-375
-
-
Tanne, D.1
Gorman, M.J.2
Bates, V.E.3
Kasner, S.E.4
Scott, P.5
Verro, P.6
Binder, J.R.7
Dayno, J.M.8
Schultz, L.R.9
Levine, S.R.10
-
24
-
-
33644551866
-
Thrombolysis for acute stroke with special emphasis on the very old: Experience from a single Dutch centre
-
van Oostenbrugge RJ, Hupperts RM, Lodder J: Thrombolysis for acute stroke with special emphasis on the very old: Experience from a single Dutch centre. J Neurol Neurosurg Psychiatry 2006; 77: 375-377.
-
(2006)
J Neurol Neurosurg Psychiatry
, vol.77
, pp. 375-377
-
-
Van Oostenbrugge, R.J.1
Hupperts, R.M.2
Lodder, J.3
-
25
-
-
78649624539
-
Thrombolysis in very elderly people: Controlled comparison of SITS international stroke thrombolysis registry and virtual international stroke trials archive
-
Mishra NK, Ahmed N, Andersen G, Egido JA, Lindsberg PJ, Ringleb PA, Wahlgren NG, Lees KR: Thrombolysis in very elderly people: Controlled comparison of SITS International Stroke Thrombolysis Registry and Virtual International Stroke Trials Archive. BMJ 2010; 341:c6046.
-
(2010)
BMJ
, vol.341
-
-
Mishra, N.K.1
Ahmed, N.2
Andersen, G.3
Egido, J.A.4
Lindsberg, P.J.5
Ringleb, P.A.6
Wahlgren, N.G.7
Lees, K.R.8
|